Clal Biotechnology Industries (XTAE:CBI) Asset Impairment Charge : ₪0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Asset Impairment Charge?

Clal Biotechnology Industries's Asset Impairment Charge for the three months ended in Dec. 2023 was ₪0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.00 Mil.

Clal Biotechnology Industries Asset Impairment Charge Historical Data

The historical data trend for Clal Biotechnology Industries's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Asset Impairment Charge Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Clal Biotechnology Industries Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

Clal Biotechnology Industries Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.